Nvidia Stock Is Struggling in 2026, and This Magnificent Seven Stock Can Make Things Worse for the Artificial Intelligence (AI) Giant. Should Investors Hit the Sell Button?

The market is likely to misread this as an immediate demand cliff for merchant GPUs, but the bigger mechanism is mix shift, not outright substitution. Meta’s internal silicon should mostly divert the lowest-ROIC inference workloads first; that trims future unit growth at the margin for NVDA, yet leaves the high-end training stack, networking, and platform lock-in intact. The more durable beneficiaries are AVGO and TSM: custom-chip design and foundry capacity monetize the same capex pool even if NVDA loses some sockets, and AVGO’s ASIC/co-design revenue is stickier than a one-off GPU sale.

The second-order effect is competitive pressure on AMD more than on NVDA in the medium term. If hyperscalers normalize custom silicon for inference, AMD’s “good-enough GPU” pitch becomes more vulnerable because customers will compare it against internally optimized ASIC economics rather than against NVDA’s best-in-class training parts. That said, the inference transition is gradual; software integration, power/thermal validation, and yield ramps usually take quarters, not weeks, so the first-order selloff risk in NVDA is more about sentiment compression than a near-term earnings reset.

Contrarian view: the consensus is underestimating how little of hyperscaler spend is actually addressable by custom chips in the next 6-12 months. Meta can reduce marginal dependence, but it still needs NVDA-class hardware for frontier models and for burst capacity when internal chips hit utilization ceilings. If NVDA guidance or backlog commentary shows no deceleration, the stock can re-rate back toward growth-premium multiples; the thesis is falsified if data-center revenue growth slows meaningfully for 2 consecutive quarters or if META meaningfully cuts GPU procurement guidance. The cleaner structural call is that custom silicon expands the AI pie rather than shrinking it, with NVDA, AVGO, and TSM all participating, just at different margin and duration profiles.